{"id":50960,"date":"2022-11-16T19:02:36","date_gmt":"2022-11-16T18:02:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/"},"modified":"2022-11-16T19:02:36","modified_gmt":"2022-11-16T18:02:36","slug":"allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/","title":{"rendered":"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies"},"content":{"rendered":"
\n

\nCompany reports 444% revenue growth from 2018 to 2021 and has also been named as one of MedTech Outlook\u2019s Top 10 Medtech Companies in Europe 2022<\/i>\n<\/p>\n

NATICK, Mass.–(BUSINESS WIRE)–Allurion<\/a>, a company dedicated to ending obesity, today announced it was named to the Deloitte Technology Fast 500<\/a>\u2122, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America. Technology Fast 500 awardees are selected based on percentage fiscal year revenue growth from 2018 to 2021. Allurion grew 444% during this period.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nAllurion Founder and Chief Executive Officer, Dr. Shantanu Gaur, attributes the company\u2019s rapid growth to the size of the market opportunity, Allurion\u2019s game-changing innovations, and best-in-class team. \u201cWe are proud of the rapid growth we have delivered in such a short period of time and have an exciting pipeline of innovations that will continue to fuel future expansion,\u201d he said. \u201cAllurion\u2019s success is a testament to the quality and caliber of our entire team and their commitment to our mission to end obesity around the world.\u201d\n<\/p>\n

\nAllurion is also announcing today that it has been named one of MedTech Outlook\u2019s \u201cTop 10 Medtech Companies in Europe 2022.\u201d\n<\/p>\n

\nThe annual listing recognizes 10 startups in Europe that are at the forefront of providing medtech solutions and transforming businesses in the region.\n<\/p>\n

\nAllurion Chief Commercial Officer, Benoit Chardon, said the international ranking and award recognizes Allurion\u2019s audacious approach to innovation. \u201cThis award not only acknowledges Allurion\u2019s innovative approach to creating the world\u2019s first full stack weight-loss platform but also the tremendous growth the company has experienced,\u201d he said. \u201cAllurion has become a strong global brand while pioneering the future of non-invasive medical weight loss. With more than 100,000 patients treated in 60 countries, we are well-positioned to penetrate new markets and help millions of people create a healthier future with our holistic weight loss program.\u201d\n<\/p>\n

\nAbout the 2022 Deloitte Technology Fast 500\u2122<\/b>\n<\/p>\n

\nNow in its 28th<\/sup> year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies \u2014 both public and private \u2014 in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2018 to 2021.\n<\/p>\n

\nIn order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company\u2019s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.\n<\/p>\n

\nAbout Allurion<\/b>\n<\/p>\n

\nAllurion is dedicated to ending obesity. The Allurion Program is a 360-degree weight loss experience featuring the Allurion Gastric Balloon, the world\u2019s first and only swallowable, procedureless* gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for clinicians featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is now available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional.\n<\/p>\n

\nLearn more about Allurion online at www.allurion.com<\/a>.\n<\/p>\n

\nAllurion is a trademark of Allurion Technologies, Inc. in the United States and countries around the world.\n<\/p>\n

\n* In rare cases, the Allurion Balloon may require endoscopic or surgical intervention for removal.\n<\/p>\n

\nAbout Deloitte<\/b>\n<\/p>\n

\nDeloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (\u201cDTTL\u201d), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as \u201cDeloitte Global\u201d) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the \u201cDeloitte\u201d name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com\/about<\/a> to learn more about our global network of member firms.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Cedric Damour
\n
PR Manager
\n
+33 7 84 21 02 20
\n
cdamour@allurion.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company reports 444% revenue growth from 2018 to 2021 and has also been named as one of MedTech Outlook\u2019s Top 10 Medtech Companies in Europe 2022 NATICK, Mass.–(BUSINESS WIRE)–Allurion, a company dedicated to ending obesity, today announced it was named to the Deloitte Technology Fast 500\u2122, a ranking of the 500 fastest-growing technology, media, telecommunications, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-50960","format-standard","category-industry"],"yoast_head":"\nAllurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company reports 444% revenue growth from 2018 to 2021 and has also been named as one of MedTech Outlook\u2019s Top 10 Medtech Companies in Europe 2022 NATICK, Mass.–(BUSINESS WIRE)–Allurion, a company dedicated to ending obesity, today announced it was named to the Deloitte Technology Fast 500\u2122, a ranking of the 500 fastest-growing technology, media, telecommunications, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T18:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221116005842\/en\/1640080\/21\/Allurion0837.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies\",\"datePublished\":\"2022-11-16T18:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/\"},\"wordCount\":715,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005842\\\/en\\\/1640080\\\/21\\\/Allurion0837.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/\",\"name\":\"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005842\\\/en\\\/1640080\\\/21\\\/Allurion0837.jpg\",\"datePublished\":\"2022-11-16T18:02:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005842\\\/en\\\/1640080\\\/21\\\/Allurion0837.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005842\\\/en\\\/1640080\\\/21\\\/Allurion0837.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/","og_locale":"en_US","og_type":"article","og_title":"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies - Pharma Trend","og_description":"Company reports 444% revenue growth from 2018 to 2021 and has also been named as one of MedTech Outlook\u2019s Top 10 Medtech Companies in Europe 2022 NATICK, Mass.–(BUSINESS WIRE)–Allurion, a company dedicated to ending obesity, today announced it was named to the Deloitte Technology Fast 500\u2122, a ranking of the 500 fastest-growing technology, media, telecommunications, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T18:02:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221116005842\/en\/1640080\/21\/Allurion0837.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies","datePublished":"2022-11-16T18:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/"},"wordCount":715,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005842\/en\/1640080\/21\/Allurion0837.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/","url":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/","name":"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005842\/en\/1640080\/21\/Allurion0837.jpg","datePublished":"2022-11-16T18:02:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221116005842\/en\/1640080\/21\/Allurion0837.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221116005842\/en\/1640080\/21\/Allurion0837.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/allurion-named-to-2022-deloitte-technology-fast-500-list-of-fastest-growing-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Allurion Named to 2022 Deloitte Technology Fast 500\u2122 List of Fastest Growing Companies"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50960","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50960"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50960\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}